Symbol not found
NASDAQ:YS 00:00AM GMT
| Market Cap (Intraday) | 77.24M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | N/A |
| 50-Day MA | N/A |
| 200-Day MA | N/A |
YS Biopharma Co Ltd Stock, NASDAQ:YS
Daxing Biomedical Industry Park, Building No.2, 38 Yongda Road, Beijing, Beijing 102600
Cayman Islands
Phone: +852.9162.5199
Number of Employees:
Description
YS Biopharma Co. Ltd. operates as a biopharmaceutical company, which is dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting rabies, Hepatitis B, shingles, influenza, and coronavirus. The company was founded in November, 2020 and is headquartered in Beijing, China.